Clinical Research Directory
Browse clinical research sites, groups, and studies.
Infant Mortality Reduction by the Mass Administration of Azithromycin
Sponsor: University of California, San Francisco
Summary
This trial will investigate the supplementation of azithromycin distribution to the "Child Health Days" platform in Burkina Faso for child mortality reduction. This distribution will pair door-to-door administration of vitamin A and azithromycin or placebo with acute malnutrition screening among children 1-11 months old.
Official title: Mortalite Infantile Reduite Par l'Administration de Masse de l'Azitromycine
Key Details
Gender
All
Age Range
1 Month - 11 Months
Study Type
INTERVENTIONAL
Enrollment
694400
Start Date
2021-10-04
Completion Date
2026-01-30
Last Updated
2025-03-13
Healthy Volunteers
Yes
Conditions
Interventions
Azithromycin
Azithromycin is a macrolide-type antibiotic that is used to treat various types of infections. Previous studies in Niger have demonstrated a nearly 18% reduction in all-cause child mortality following biannual mass administration to children 1-59 months.
Placebo
Matching identical placebo in packaging, appearance, and taste.
Locations (3)
University of California, San Francisco
San Francisco, California, United States
Centre de Recherche en Sante de Nouna
Nouna, Burkina Faso
Helen Keller International
Ouagadougou, Burkina Faso